Drug Shortage Report for TEVA-5 ASA
Report ID | 138904 |
Drug Identification Number | 02171929 |
Brand name | TEVA-5 ASA |
Common or Proper name | ASA 400MG TAB |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | MESALAZINE |
Strength(s) | 400MG |
Dosage form(s) | TABLET (ENTERIC-COATED) |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | A07EC |
ATC description | INTESTINALANTIINFLAMMATORY AGENTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2021-05-05 |
Estimated end date | 2021-06-30 |
Actual end date | 2021-06-09 |
Shortage status | Resolved |
Updated date | 2021-06-10 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2021-06-10 | French | Compare |
v5 | 2021-06-10 | English | Compare |
v4 | 2021-05-10 | French | Compare |
v3 | 2021-05-10 | English | Compare |
v2 | 2021-05-06 | French | Compare |
v1 | 2021-05-06 | English | Compare |
Showing 1 to 6 of 6